Holen Sie sich die Stockscreener-App
5.80
0.35%
0.02
Handel nachbörslich:
6.11
0.31
+5.34%
Schlusskurs vom Vortag:
$5.78
Offen:
$5.78
24-Stunden-Volumen:
43,353
Relative Volume:
1.66
Marktkapitalisierung:
$6.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-57.11M
KGV:
-0.3867
EPS:
-15
Netto-Cashflow:
$-34.82M
1W Leistung:
+4.13%
1M Leistung:
+6.42%
6M Leistung:
-19.11%
1J Leistung:
-58.72%
1-Tages-Spanne:
$5.50
$6.28
1-Wochen-Bereich:
$5.50
$6.38
52-Wochen-Spanne:
$4.4701
$35.98
Apollomics Inc Stock (APLM) Company Profile
Vergleichen Sie APLM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
5.80 | 6.38M | 0 | -57.11M | -34.82M | -15.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Apollomics Inc Aktie (APLM) Neueste Nachrichten
How to build a custom watchlist for Apollomics Inc.2025 Stock Rankings & Safe Entry Trade Reports - Newser
Automated trading signals detected on Apollomics Inc.Bond Market & Community Shared Stock Ideas - Newser
Volatility clustering patterns for Apollomics Inc.Weekly Trade Analysis & High Accuracy Swing Entry Alerts - Newser
Will a bounce in Apollomics Inc. offer an exitWeekly Earnings Recap & Low Risk Investment Opportunities - Newser
Apollomics Inc. Equity Warrant stock trend outlook and recovery path - Newser
Should you wait for a breakout in Apollomics Inc.2025 Buyback Activity & Target Return Focused Picks - Newser
Is Apollomics Inc. still worth holding after the dipJuly 2025 EndofMonth & Low Drawdown Momentum Ideas - Newser
Long term hold vs stop loss in Apollomics Inc. Equity WarrantInsider Selling & High Yield Stock Recommendations - Newser
Combining price and volume data for Apollomics Inc. Equity WarrantJuly 2025 Outlook & Low Risk High Win Rate Picks - Newser
Understanding Apollomics Inc.’s price movementMarket Trend Summary & High Accuracy Swing Trade Signals - Newser
Is Apollomics Inc. Equity Warrant stock bottoming outWeekly Trade Report & Precise Swing Trade Entry Alerts - Newser
How Apollomics Inc. Equity Warrant stock performs during market volatility2025 Fundamental Recap & Technical Buy Zone Confirmations - Newser
How hedge fund analytics apply to Apollomics Inc. Equity Warrant stockTrade Performance Summary & Detailed Earnings Play Alerts - Newser
Using Python tools to backtest Apollomics Inc. Equity Warrant strategiesBuy Opportunity Forecast for Fast Traders - Newser
Can Apollomics Inc. rally from current levels [2025 Bull vs Bear]Daily Growth Stock Tips - Newser
How Apollomics Inc. Equity Warrant stock performs during market volatility [Quarterly Trade Review]Risk Managed Investment Strategies - Newser
C-Met Mutated Non-Small Cell Lung Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Novartis, Apollomics Inc., Abbvie, Janssen Research and Developm - Barchart.com
Technical analysis overview for Apollomics Inc. stockFree Sector Based Breakout Stock Forecast - Newser
What high frequency data says about Apollomics Inc. Equity WarrantFree Watchlist for Low Risk High Return - Newser
Key metrics from Apollomics Inc.’s quarterly dataFree Target Return Focused Trade Insights - Newser
Can technical indicators confirm Apollomics Inc. Equity Warrant’s reversalInvestment Roadmap for High Potential Stocks - Newser
What earnings revisions data tells us about Apollomics Inc.Chart Signal and Short-Term Forecast Tracker - Newser
Real time breakdown of Apollomics Inc. stock performanceTrend Reversal Probability Forecast Update - Newser
Published on: 2025-08-11 22:47:12 - Newser
Heatmap analysis for Apollomics Inc. and competitorsFree Strong Buy With Technical Confidence - Newser
Combining price and volume data for Apollomics Inc.High Return Strategy with Low Risk - Newser
Is Apollomics Inc. Equity Warrant Stock Overbought or Oversold RSI Indicator AnalysisFree Consistent Profit Pattern Recognition Tools - Newser
Why Apollomics Inc. Equity Warrant stock attracts strong analyst attentionFree Beginner Friendly Stock Selection Guide - Newser
What MACD signals say about Apollomics Inc. Equity WarrantMulti-Year Investment Performance Summary Report - Newser
Is now a turning point for Apollomics Inc.Predictable Return Plan with Entry Guidance - Newser
Apollomics Inc. stock trend forecastPredictive Analytics for Equity Growth Potential - Newser
Ranking Apollomics Inc. among high performing stocks via toolsEquity Forecast with Predictive AI Screener - Newser
Published on: 2025-08-11 02:08:57 - Newser
Can Apollomics Inc. rally from current levelsForecast Model for Intraday Buy Signals - Newser
When is the best time to exit Apollomics Inc.Free Stable Entry High Return Opportunities - Newser
Apollomics Inc. Equity Warrant stock volume spike explainedReal-Time AI Sentiment and Price Forecast - Newser
Chart overlay techniques for tracking Apollomics Inc. Equity WarrantFree Wealth Building Stock Market Ideas - Newser
What makes Apollomics Inc. Equity Warrant stock price move sharplyFree Risk-Adjusted Picks With Exit Strategy - Newser
Is Apollomics Inc. Equity Warrant Stock a Smart Buy in 2025 Investment Analysis InsideFree Accurate Technical Trend Reversal Picks - Newser
Chart based analysis of Apollomics Inc. trendsRisk Shielded Trade Watch with Analysis - Newser
Regression analysis insights on Apollomics Inc. Equity Warrant performanceFree Weekly Stock Watch With Growth Focus - Newser
Finanzdaten der Apollomics Inc-Aktie (APLM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):